Abstract: Methods, compositions, systems, devices and kits are provided herein for preparing and using a nanoparticle composition and spatial frequency heterodyne imaging for visualizing cells or tissues. In various embodiments, the nanoparticle composition includes at least one of: a nanoparticle, a polymer layer, and a binding agent, such that the polymer layer coats the nanoparticle and is for example a polyethylene glycol, a polyelectrolyte, an anionic polymer, or a cationic polymer, and such that the binding agent that specifically binds the cells or the tissue. Methods, compositions, systems, devices and kits are provided for identifying potential therapeutic agents in a model using the nanoparticle composition and spatial frequency heterodyne imaging.
Type:
Grant
Filed:
October 5, 2012
Date of Patent:
April 19, 2016
Assignees:
BROWN UNIVERSITY, RHODE ISLAND HOSPITAL
Inventors:
Christoph Rose-Petruck, Jack R. Wands, Danielle Rand, Zoltan Derdak, Vivian Ortiz
Abstract: This invention relates to methods for treating, preventing, or reversing brain disease or damage produced by chronic alcohol intake by administering a peroxisome proliferator activated receptor (PPAR) agonist.
Type:
Grant
Filed:
September 10, 2007
Date of Patent:
April 12, 2016
Assignee:
RHODE ISLAND HOSPITAL
Inventors:
Jack R. Wands, Suzanne Marie de la Monte
Abstract: The method for large scale production of a full length Schistosomal paramyosin coiled coil dimer composition is carried out by providing a composition comprising recombinant paramyosin, contacting the composition with a strand separation agent to remove paramyosin fragments and other contaminants. The purified paramyosin is used in vaccines for humans and bovine animals to induce immunity against schistosomal infection.
Type:
Grant
Filed:
November 5, 2008
Date of Patent:
March 15, 2016
Assignee:
Rhode Island Hospital
Inventors:
Jonathan Kurtis, Mario Jiz, Haiwei Wu, Sunthorn Pond-Tor
Abstract: A method of radiotherapy treatment planning is described. A planned target volume is identified for radiotherapy treatment and at least one volume of interest is identified. The mass, density, and total deposited energy contained in the planned target volume and the volumes of interest are identified and dose objectives are determined. At least one of the objectives is a function of the identified mass, density, or deposited energy. A composite objective function is determined using the dose objectives for the planned target volume and the volumes of interest. A near optimal solution to the composite objective function is determined to produce a radiotherapy treatment plan.
Abstract: This application discloses compositions, devices, and methods for the prevention and treatment of osteolysis and osteoporosis. Treatment or prevention of osteolysis or osteoporosis is carried out by targeting the enzyme, Shp2 (a Src homology 2 (SH2) domain containing non-transmembrane Protein Tyrosine Phosphatase (PTP)), or proteins involved in the Shp2 signaling pathway by administering a Shp2 pathway inhibitor that inhibits fusion of pre-osteoclasts.
Type:
Application
Filed:
January 16, 2014
Publication date:
December 10, 2015
Applicant:
RHODE ISLAND HOSPITAL
Inventors:
Wentian Yang, Michael G. Ehrlich, Yi Zhou, Douglas Moore
Abstract: A system including a processor configured to be coupled to an electrical lead that is configured to sense electrical activity in a patient, a memory coupled to the processor, the memory containing computer readable instructions that, when executed by the processor, cause the processor to detect a pain signature in the sensed electrical activity, determine a treatment protocol in response to the detected pain signature, and cause the treatment protocol to be delivered to the patient via the electrical lead.
Abstract: The present disclosure provides biomaterials and methods for preventing and minimizing progression of cartilage and/or connective tissue damage. Also provided herein are biomaterials and methods for alleviating and/or reducing the risk for developing arthritis (e.g., osteoarthritis) associated with joint injury and/or joint surgery.
Type:
Application
Filed:
February 1, 2013
Publication date:
December 18, 2014
Applicants:
Children's Medical Center Corporation, Rhode Island Hospital
Abstract: The invention relates to inhibition of SDF-1? expression in subacromial bursa cells by CXCR-4 inhibitors. Bursal cell migration in response to SDF-? stimulation is also decreased in the presence of CXCR4 inhibitors. Accordingly, provided are methods for treating or ameliorating a musculoskeletal disorder.
Abstract: The invention features a tribonectin and a method of tribosupplementation carried out by administering tribonectins directly to an injured or arthritic joint.
Abstract: A controller with a conformable fitting system is configured for controlling a device, such as a toy or game, is pliable, flexible and cushioning to provide a custom fit of the device controller to the body part of the patient or user. The device controller spans across a joint, such as a wrist, and includes a pivot between preferably two main portions. The rotation axis of the device controller is aligned with the pivot axis of the joint to receive the physical therapy. A sensor, such as a digital encoder, is located proximal thereto to determine the relative positioning of the main portions to each other. The sensor electronically communicates with the device, such as a toy or game, to serve as a controller therefor.
Abstract: The invention features a tribonectin and a method of tribosupplementation carried out by administering tribonectins directly to an injured or arthritic joint.
Abstract: A participant, engages in healthcare provider prescribed physical rehabilitation exercises utilizing specifically designed controllers, and these exercises are mapped to one or more video game commands. These commands are coupled with other inputs to control the video game that will be used to ensure adherence to a prescribed rehabilitation regimen. Information is gathered on the participant, in order to aid in rehabilitation.
Type:
Application
Filed:
September 12, 2013
Publication date:
March 20, 2014
Applicants:
Rhode Island Hospital, Brown University
Inventors:
Angus Kingon, John Donoghue, Yi-Ning Wu, Karen Kerman, Brian Monetti
Abstract: Methods for reducing the severity of an arthritic condition or repairing an osteochondral defect are carried out by administering to a subject compositions comprising a member of the matrilin family of proteins, e.g., a matrilin protein, fragment thereof, or nucleic acid encoding the protein or fragment.
Abstract: A method of radiotherapy treatment planning is described. A planned target volume is identified for radiotherapy treatment and at least one volume of interest is identified. The mass, density, and total deposited energy contained in the planned target volume and the volumes of interest are identified and dose objectives are determined. At least one of the objectives is a function of the identified mass, density, or deposited energy. A composite objective function is determined using the dose objectives for the planned target volume and the volumes of interest. A near optimal solution to the composite objective function is determined to produce a radiotherapy treatment plan.
Abstract: Disclosed are novel methods of maintaining articular cartilage health in an atraumatic, non-diseased joint of a mammal, either human or non-human. The methods involve injecting into the joint capsule of the mammal an amount of a lubricin polypeptide to prevent shear-induced chondrocyte apoptosis and to maintain a lubricin-expressing phenotype of chondrocytes.
Type:
Application
Filed:
October 4, 2012
Publication date:
May 9, 2013
Applicant:
Rhode Island Hospital, A Lifespan Partner
Inventor:
Rhode Island Hospital, A Lifespan Partner
Abstract: The invention features a tribonectin and a method of tribosupplementation carried out by administering tribonectins directly to an injured or arthritic joint.
Abstract: A system including a processor configured to be coupled to an electrical lead that is configured to sense electrical activity in a patient, a memory coupled to the processor, the memory containing computer readable instructions that, when executed by the processor, cause the processor to detect a pain signature in the sensed electrical activity, determine a treatment protocol in response to the detected pain signature, and cause the treatment protocol to be delivered to the patient via the electrical lead.
Abstract: A controller with a conformable fitting system is configured for controlling a device, such as a toy or game, is pliable, flexible and cushioning to provide a custom fit of the device controller to the body part of the patient or user. The device controller spans across a joint, such as a wrist, and includes a pivot between preferably two main portions. The rotation axis of the device controller is aligned with the pivot axis of the joint to receive the physical therapy. A sensor, such as a digital encoder, is located proximal thereto to determine the relative positioning of the main portions to each other. The sensor electronically communicates with the device, such as a toy or game, to serve as a controller therefor.